TIAR is also a negative regulator of the BRCA1 oncogene; it has been shown to block translation and reduce the protein expression of BRCA1 in chronic myeloid leukemia cells, which leads to aneuploidy, spindle toxin resistance and genomic instability [164]. This evidence concerns the gene BRCA1 and chronic myelogenous leukemia, BCR-ABL1 positive.